GENMAB A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,004 DKK | -2.77% |
|
+2.53% | -7.01% |
| May. 03 | GENMAB : A good start to 2024; guidance unchanged |  |
| May. 03 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | -2.77% | +2.53% | -7.01% | -26.62% | +80.46% | 19.25B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Comparison Chart